India's Zydus Lifesciences reported third-quarter profit above analysts' expectations on Wednesday, driven by strong demand for its generic drugs in its key U.S. market.

Quarterly Net Profit at Rs. 470.60 crore in December 2024 up 4.48% from Rs. 450.40 crore in December 2023. EBITDA stands at ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Zydus Life's Earnings Before Interest, Tax, Depreciation, and Amortisation (EBITDA) reached Rs 1,387 crore for the relevant period, compared to Rs 1,102 crore in the same quarter of the previous year.

The company posted Capex (organic) for the quarter at Rs. 290.7 crore. Zydus Life said that its Research & Development (R&D) investments for the quarter stood at Rs 503.10 crore (9.5% of revenues).

Zydus Life, Solar Industries, Cummins India, Abbott India, Page Industries, etc will announce their quarterly earnings today. Apart from these companies Data Patterns, Tega Industries, Mr Bectors ...

International Markets Revenue: INR 5.7 billion, up 16% year-on-year. Zydus Lifesciences Ltd (BOM:532321) reported a strong financial performance with consolidated revenues of INR 52.7 billion ...

Zydus Lifesciences Limited reported a 30 per cent year-on-year increase in net profit to ₹1,023.5 crore for the quarter ended December 31, 2024, driven by robust performance in its US ...

International Markets Revenue: INR 5.7 billion, up 16% year-on-year. Zydus Lifesciences Ltd (BOM:532321) reported a strong financial performance with consolidated revenues of INR 52.7 billion, up 17% ...

Over a hundred companies, including Swiggy and Reliance Power, will announce quarterly earnings. The Indian stock market ...